$BILI···bullish· highunknown BillionToOne goes public at $4B+ valuation with 20% prenatal market share and liquid biopsy pipeline
BillionToOne's synthetic DNA spike-in technology solves PCR amplification noise, enabling ultra-sensitive liquid biopsy for prenatal testing and cancer detection; the company has…